News Articles Tagged: CNS Metastasis

The Role of AZD3759 in Advancing Brain Metastasis Treatment for NSCLC

Explore AZD3759's role in treating NSCLC brain metastases, highlighting its superior CNS penetration and efficacy as a potent EGFR TKI.

Focus on AZD3759: Advancing Treatment for Lung Cancer with CNS Involvement

Learn about AZD3759, a potent EGFR TKI with superior CNS penetration, offering new hope for EGFR-mutant NSCLC patients with brain metastases.

The Science Behind AZD3759: A New Era for Lung Cancer Brain Metastasis Treatment

Delve into the scientific advancements of AZD3759, a CNS-penetrant EGFR TKI revolutionizing lung cancer care, particularly for EGFR-mutant NSCLC with brain metastases.